Alpine Immune Sciences Investor Relations Material

Alpine Immune Sciences Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory diseases, as well as cancer. The company uses its proprietary platform to engineer protein-based therapies that modulate the immune system to enhance treatment efficacy. Alpine's approach aims to create novel immunotherapies that target immune pathways, offering potential treatments for patients with unmet medical needs in areas such as immuno-oncology and autoimmune disorders. Its pipeline includes a range of drug candidates designed to address these conditions. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.